User profiles for Barry Kevane

Barry Kevane

Verified email at mater.ie
Cited by 874

[HTML][HTML] COVID-19 induces a hyperactive phenotype in circulating platelets

…, B McCullagh, N Moran, F Ní Áinle, B Kevane… - PLoS …, 2021 - journals.plos.org
Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), has affected over 30 million globally to date. Although …

[HTML][HTML] Anticoagulation practice patterns in COVID‐19: a global survey

…, M Huisman, BJ Hunt, SR Kahn, B Kevane… - Research and practice …, 2020 - Elsevier
Background Best practice for prevention, diagnosis, and management of venous
thromboembolism (VTE) in patients with coronavirus disease 2019 (COVID‐19) is unknown due to …

Risk factors for pregnancy-associated venous thromboembolism: a review

B Kevane, J Donnelly, M D'Alton, S Cooley… - Journal of perinatal …, 2014 - degruyter.com
Aim: To critically evaluate current understanding of risk factors for pregnancy-associated
venous thromboembolism (VTE) and to describe underlying molecular mechanisms. Methods: …

Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?

FN Áinle, B Kevane - Blood advances, 2020 - ashpublications.org
Recurrent venous thromboembolism (VTE, or deep vein thrombosis and pulmonary embolism)
is associated with mortality and long-term morbidity. The circumstances in which an index …

[HTML][HTML] Routine hematological parameters may be predictors of COVID-19 severity

…, A Lennon, B McCullagh, F Ni Ainle, B Kevane… - Frontiers in …, 2021 - frontiersin.org
To date, coronavirus disease 2019 (COVID-19) has affected over 100 million people globally.
COVID-19 can present with a variety of different symptoms leading to manifestation of …

Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis

…, PB Maguire, F Ní Áinle, B Kevane - … of Thrombosis and …, 2022 - Wiley Online Library
Background Hypercoagulability and endothelial dysfunction are hallmarks of coronavirus
disease 2019 (COVID‐19) and appear to predict disease severity. A high incidence of …

Elevated venous thromboembolism risk in preeclampsia: molecular mechanisms and clinical impact

K Egan, B Kevane, FN Áinle - Biochemical Society Transactions, 2015 - portlandpress.com
Venous thromboembolism (VTE) remains a leading cause of maternal death and morbidity
in the developed world. Strategies for prevention of VTE in pregnancy have been the subject …

Platelets, extracellular vesicles and coagulation in pulmonary arterial hypertension

…, L Weiss, SP Comer, B Kevane… - Pulmonary …, 2021 - journals.sagepub.com
Pulmonary arterial hypertension is a rare disease of the pulmonary vasculature, characterised
pathologically by proliferation, remodelling and thrombosis in situ. Unfortunately, existing …

Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism

…, HD O'Connor, C Kirkham, B Kevane… - Journal of thrombosis …, 2017 - Springer
Venous thromboembolism (VTE) remains a leading cause of maternal morbidity and mortality
in the developed world. Low molecular weight heparins (LMWH) are routinely used to …

Alterations in fibrin formation and fibrinolysis in early onset-preeclampsia: Association with disease severity

…, C Monteith, H O'Connor, B Kevane… - European Journal of …, 2019 - Elsevier
Objective ; Early-onset preeclampsia is a rare pregnancy-specific disorder associated with
significantly increased maternal and fetal morbidity and mortality. Whilst it is known that even …